Show
Sort by
-
- Journal Article
- A1
- open access
Respiratory viruses in patients with hematological malignancy in boreal autumn/winter 2023–2024 : EPICOVIDEHA-EPIFLUEHA report
-
- Journal Article
- A1
- open access
Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic : results from the epicovideha registry
-
- Journal Article
- A1
- open access
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients : results from the EPICOVIDEHA registry
-
- Journal Article
- A1
- open access
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies : results from the EPICOVIDEHA survey
-
- Journal Article
- A1
- open access
Decoding the historical tale : COVID-19 impact on haematological malignancy patients : EPICOVIDEHA insights from 2020 to 2022
-
- Journal Article
- A1
- open access
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19 : matched-paired analysis in the EPICOVIDEHA registry
-
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post CD19-CAR-T : an EPICOVIDEHA survey
-
- Journal Article
- A1
- open access
Outcome of COVID-19 in allogeneic stem cell transplant recipients : results from the EPICOVIDEHA registry
-
- Journal Article
- A1
- open access
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe : a matched-paired analysis from the EPICOVIDEHA registry
-
- Journal Article
- A1
- open access
COVID-19 in adult acute myeloid leukemia patients : a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)